Journal Home
Search for

Volume 73, Issue 6, Pages 1014-1016 (December 2009)


View previous. 37 of 69 View next.

Myosin heavy chain proteins are responsible for the development of obstructive sleep apnea syndrome

Jiří ŠedýabCorresponding Author Informationemail address, Edita Horkáb, Gabriela Pavlíkovác, Oliver Bulíkd, René Foltánc

Received 14 April 2009; accepted 18 April 2009. published online 24 June 2009.

Summary 

We introduce a hypothesis that obstructive sleep apnea syndrome (OSAS) is primarily caused by an inherited reduced adaptability of upper airway striated muscles such that they cannot maintain patency when there is reduced consciousness (sleep). This reduced ability is caused by a deficiency of the genes for specific myosin heavy chain (MHC) proteins, which are the primary source of muscle adaptability in adults and were initially described in the chewing muscles. The development of OSAS must be linked to problems with striated muscle because affected patients are capable of normal breathing when awake but their respiratory parameters deteriorate during sleep; OSAS must, therefore, be caused by a factor that is voluntarily active during waking but inactive during sleep, and this can only be striated muscle. Congenital or acquired anatomical abnormalities are involved only partially, because OSAS patients with anatomical abnormalities do not begin to snore or to have apneas or hypopneas when lying in bed awake, but begin to do so only when sleeping.

a Institute of Experimental Medicine and Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic

b Institute of Dental Research, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic

c Division of Oral and Maxillofacial Surgery, Department of Stomatology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic

d Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Masaryk University, Brno, Czech Republic

Corresponding Author InformationCorresponding author. Address: Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20 Prague 4, Czech Republic. Tel.: +420 241062717; fax: +420 241062783.

PII: S0306-9877(09)00372-7

doi:10.1016/j.mehy.2009.04.051


View previous. 37 of 69 View next.